Home
Home

Cipla

Enbrel's Asian Biosimilar Competitors

Enbrel's Asian Biosimilar Competitors
Seeking Alpha

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug
Fierce Pharma

Glaxo, Cipla Seen as Biggest Losers as India Sets Prices

Glaxo, Cipla Seen as Biggest Losers as India Sets Prices
Bloomberg

Cipla, Aspen eye joint excursion in Australia

Cipla, Aspen eye joint excursion in Australia
Fierce Pharma

India's Cipla Q2 net up 17.5 pct, beats f'cast

India's Cipla Q2 net up 17.5 pct, beats f'cast
Reuters

Cipla eyes alliances to grow in emerging markets

Cipla eyes alliances to grow in emerging markets
Fierce Pharma

Takeda in talks with Lupin, Cipla to buy pharma businesses

Takeda in talks with Lupin, Cipla to buy pharma businesses
Stock Market Digital

News

India Rejects Patent Application for Abbott’s Kaletra
Bloomberg

News

Shopping for generic buyouts? Here's a list
Fierce Pharma
»

News

Dr. Reddy’s, Cipla May Be Targets, First Global Says
Bloomberg
»